🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Cortical Development Malformation

Clinical Trial Readiness for the Dystroglycanopathies NCT00313677n/a1 site📍 Iowa City Katherine Mathews The FBRI VTC Neuromotor Research Clinic NCT03325946n/a1 site📍 Roanoke Virginia Polytechnic Institute and State University · Tests: ACQUIRE Therapy PTEN Hamartoma Tumor Syndrome Pediatric Patient Registry NCT06462430n/a1 site📍 Istanbul Yale University Study of the Disease Process of Lymphangioleiomyomatosis NCT00001465n/a1 site📍 Bethesda National Heart, Lung, and Blood Institute (NHLBI) · Tests: Toshibia Aquilion One CT Treatment With Full-spectrum Cannabis Extract of Refractory Epilepsy Associated With Tuberous Sclerosis Complex (TSC) NCT07403266Phase 31 site📍 Madrid Oils4Cure · Tests: YCJ-01 Full Spectrum cannbis Extract, Placebo Exploration and Evaluation of Amygdalo-Hippocampectomy According to Prof. Coubes' Technique: An Anatomical, Clinical, and Educational Approach NCT06915649n/a1 site📍 Montpellier University Hospital, Montpellier · Tests: Amygdalo-Hippocampectomy GROWing Up With Rare GENEtic Syndromes NCT04463316n/a1 site📍 Rotterdam dr. Laura C. G. de Graaff-Herder · Tests: Retrospective file studies Genetic and Electrophysiologic Study in Focal Drug-resistant Epilepsies NCT02890641n/a1 site📍 Paris Fondation Ophtalmologique Adolphe de Rothschild · Tests: Sampling of blood, frozen resected tissues, and cerebrospinal fluid (CSF) Sapu003 in Advanced mTOR-sensitive Solid Tumors NCT07369505Phase 11 site📍 Adelaide SAPU NANO (US) LLC · Tests: Sapu003, Exemestane 25 MG MEHMO Natural History and Biomarkers NCT06019182n/a1 site📍 Bethesda Eunice Kennedy Shriver National Institute of Child Health a… Qualitative Study in Patients With Genodermatoses and Healthcare Professionals on Reproductive Counselling NCT06330350n/a1 site📍 Maastricht Maastricht University Medical Center · Tests: Qualitative interview AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy NCT06063850Phase 1, Phase 218 sites📍 Birmingham📍 Phoenix📍 Palo Alto UniQure Biopharma B.V. · Tests: AAV9-hSyn1-miGRIK2 Melpida: Recombinant Adeno-associated Virus (Serotype 9) Encoding a Codon Optimized Human AP4M1 Transgene (hAP4M1opt) NCT05518188Phase 1, Phase 21 site📍 Dallas Elpida Therapeutics SPC · Tests: MELPIDA Familial Investigations of Childhood Cancer Predisposition NCT03050268n/a1 site📍 Memphis St. Jude Children's Research Hospital Long-Term Development of Muscular Dystrophy Outcome Assessments NCT05989620n/a1 site📍 Richmond Virginia Commonwealth University Mos-FED (Mosaicism in Focal Epilepsy Cortical Dysplasia Tissue) NCT06053671NA1 site📍 London King's College Hospital NHS Trust · Tests: Blood and nasal swab sampling TSC Biosample Repository and Natural History Database NCT05676099n/a26 sites📍 Birmingham📍 Loma Linda📍 Los Angeles National Tuberous Sclerosis Association · Tests: Phlebotomy, Buccal (cheek) swab, Genetic Testing, Tissue donation after routine clinical procedure Speech-in-noise Perception in Autism and Fragile X NCT06088589NA1 site📍 Cincinnati Children's Hospital Medical Center, Cincinnati · Tests: Mismatch negativity Human Epilepsy Genetics--Neuronal Migration Disorders Study NCT00041600n/a1 site📍 Boston Harvard University Faculty of Medicine Placebo Controlled Study to Assess the Efficacy and Safety of Rapamycin in Drug Resistant Epilepsy Associated With Tuberous Sclerosis Complex NCT05534672Phase 32 sites📍 Lodz📍 Warsaw Katarzyna Kotulska · Tests: Rapamycin, Placebo Efficacy and Safety of Rapamycin Versus Vigabatrin in the Prevention of Tuberous Sclerosis Complex Symptoms in Infants NCT04987463Phase 2, Phase 32 sites📍 Warsaw📍 Warsaw Katarzyna Kotulska · Tests: Vigabatrin, Rapamycin, Placebo, Placebo Register for Patients With Thyroid Hormone Resistance. NCT06566066n/a1 site📍 Berlin Charite University, Berlin, Germany · Tests: no intervention Study of Skin Tumors in Tuberous Sclerosis NCT00001975n/a1 site📍 Bethesda National Heart, Lung, and Blood Institute (NHLBI) Periodontal Disease in Rare Renal Disorders (PERIO-RA-RE) NCT07575347n/a1 site📍 Bucharest Stefan Lujinschi · Tests: Observational assessment Normative Brain Volume Profiles From Multicenter Fetal MRI NCT06081036n/a1 site📍 Marseille Assistance Publique Hopitaux De Marseille · Tests: Questionnaire Tuberous Sclerosis Complex and Lymphangioleiomyomatosis Pregnancy Registry (TSC-LAM Registry) NCT06160310n/a1 site📍 Cincinnati David M. Ritter Brain Development Research Program NCT00305305n/a1 site📍 San Francisco University of California, San Francisco Cartography of Social Cognition Network and Their Alterations in Patients With Epilepsy NCT05527093NA2 sites📍 Gif-sur-Yvette📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: MRI 3T and MRI 7T National Registry of Rare Kidney Diseases NCT06065852n/a1 site📍 Bristol UK Kidney Association Role of Genetic Factors in the Development of Lung Disease NCT00001532n/a2 sites📍 Bethesda📍 Bethesda National Heart, Lung, and Blood Institute (NHLBI)
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy